WEBB MICHAEL D 4

What Happened

• Michael D. Webb, a director of Enveric Biosciences, was granted 18,518 restricted shares on 2026-06-01. The shares were reported as an award/acquisition (code A) at $0.00 per share (total reported value $0).
• This is a restricted stock grant under the company’s long-term incentive plan, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-01 (Form 4 filed 2026-06-03).
• Transaction type/code: Award/Grant (A).
• Shares granted: 18,518; reported acquisition price: $0.00; reported total value: $0.
• Shares owned after the transaction: not specified in the filing.
• Footnote: Shares are restricted stock granted under the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan and will vest according to the Plan and the reporting person’s restricted stock award agreement.
• Timeliness: Filing appears timely (reported two days after the grant).

Context

• Restricted stock awards typically vest over time per the award agreement; they are not immediate open-market purchases and do not by themselves signal intent to buy or sell shares.
• For retail investors, grants to directors are common as compensation/retention tools; track vesting schedules and subsequent sales for clearer insider conviction signals.